Skip to Main content Skip to Navigation
Journal articles

Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC- Abolishes Ewing Sarcoma Growth in vivo

Abstract : Identification of druggable targets is a prerequisite for developing targeted therapies against Ewing sarcoma. We report the identification of Protein Kinase C Beta (PRKCB) as a protein specifically and highly expressed in Ewing sarcoma as compared to other pediatric cancers. Its transcriptional activation is directly regulated by the EWSR1-FLI1 oncogene. Getting insights in PRKCB activity we show that, together with PRKCA, it is responsible for the phosphorylation of histone H3T6, allowing global maintenance of H3K4 trimethylation on a variety of gene promoters. In the long term, PRKCB RNA interference induces apoptosis in vitro. More importantly, in xenograft mice models, complete impairment of tumor engraftment and even tumor regression were observed upon PRKCB inhibition, highlighting PRKCB as a most valuable therapeutic target. Deciphering PRKCB roles in Ewing sarcoma using expression profiling, we found a strong overlap with genes modulated by EWSR1-FLI1 and an involvement of RPKCB in regulating crucial signaling pathways. Altogether, we show that PRKCB may have two important independent functions and should be considered as highly valuable for understanding Ewing sarcoma biology and as a promising target for new therapeutic approaches in Ewing sarcoma.
Complete list of metadata

Cited literature [22 references]  Display  Hide  Download
Contributor : Franck Tirode Connect in order to contact the contributor
Submitted on : Tuesday, January 14, 2020 - 12:27:40 PM
Last modification on : Wednesday, October 27, 2021 - 4:05:11 PM
Long-term archiving on: : Wednesday, April 15, 2020 - 5:35:02 PM


Files produced by the author(s)



Didier Surdez, Magdalena Benetkiewicz, V. Perrin, Zhi-Yan Han, Gaëlle Pierron, et al.. Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC- Abolishes Ewing Sarcoma Growth in vivo. Cancer Research, American Association for Cancer Research, 2012, 72 (17), pp.4494-4503. ⟨10.1158/0008-5472.CAN-12-0371⟩. ⟨inserm-02438737⟩



Les métriques sont temporairement indisponibles